chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a 67-year-old female patient regarding herself. Current conditions included allergy to codeine. The patient was vaccinated with ZOSTAVAX (lot # not reported) dosing details not reported for prophylaxis (reported as shingles vaccine) subcutaneously on 06-SEP-2012. Other suspect therapies included PNEUMOVAX 23 (lot # not reported) on 28-AUG-2012. Patient stated on 06-SEP-2012 she had redness and irritation at the injection site, no other side effects was noted. Patient questioned the efficacy of PNEUMOVAX 23 and ZOSTAVAX after 8 days. No treatment was given for the events. The patient did not recover from the events at the time of this report. Medical attention was not sought for the events. No further AE information provided. Additional information has been requested.
mom reports pt fever 102 18JUL95 a/bed APAP given; pt seemed okay; 19JUL fever went to 104; 20JUL pt became jerky taken to local ER told pt had otitis; rx Amoxicillin, Ibuprofen, APAP reportedly told probably not true sz;
Soreness or achhiness; This case was reported by a consumer via call center representative and described the occurrence of pain in a 73-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Influenza vaccine Quadrivalent unspecified season.  Additional information received were as follows: The age at vaccination was not reported. The patient experienced soreness or achhiness. This case has been linked with US2019148654, reported by the same reporter.
Shingrix shot 3 years, never received the 2nd dose; This case was reported by a consumer and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received about 3 years ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not applicable for this report. The patient had never received the 2nd dose of Shingrix till the time of reporting which led to incomplete course of vaccination.  The reporter also asked what should he/she do if want to get vaccinate. No contact details were reported.
Patient became extremely lightheaded after vaccination (MMR). We called emergency services after patient was not responding to our questions. Emergency services called. EMT's came and checked BP Then pt. refused rest of their care. She said she felt better.
I got Pfizer Lot EN6200 on 02/26/2021 around 3:30 pm in my left deltoid. The 'blister' is on my right hand index finger (measured 9 mm by 7 mm at its widest points, has not changed size or character since appearing) with a fainter in color 'blister' (5 mm by 3 mm at widest) present on my right hand pinkie. No 'trauma' to the site. Nonblanching, two petechiae present within the ring finger's blister, two also present in the one on my pinky. Those petechiae have disappeared in the last two days, but the spots are still present. Red, not warm, sensitive to touch. I had no other symptoms from dose one of the vaccination, outside of a sore arm and some joint pain. Possibly fatigue, but that's likely just me being fatigued as per usual.
Red spots on side of head down the neck and red swollen eye. Seen at Med urgent care
I am 64yo & had 2pfizer vaccines + 2pfizer boosters/tested "Positive"; I am 64yo & had 2pfizer vaccines + 2pfizer boosters/tested "Positive"; retested "Negative" 1day after stopping Paxlovid but I am now "Positive" again 2 days later; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:. The reporter is the patient.  A 64-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DISEASE RECURRENCE (medically significant) with onset 2022, outcome "not recovered", described as "retested "Negative" 1day after stopping Paxlovid but I am now "Positive" again 2 days later"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 21Aug2022, outcome "not recovered" and all described as "I am 64yo & had 2pfizer vaccines + 2pfizer boosters/tested "Positive"". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Negative, notes: retested "Negative" 1day after stopping Paxlovid; (2022) Positive, notes: I am now "Positive" again 2 days later; (21Aug2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: I am 64yo & had 2 Pfizer vaccines + 2 Pfizer boosters (as did my husband also 64). He tested "Positive" on 18Aug2022 and I tested "Positive" on 21Aug2022. Both of our 23yo twins tested "Positive" 1&3 days later. My husband and I each took 5-day regimen of Paxlovid. Two days after stopping Paxlovid he retested "Negative" & I retested "Negative" 1day after stopping Paxlovid but I am now "Positive" again 2 days later. Neither kid took Paxlovid & are both still "Positive" but had same symptoms as we did. Any guidance on Paxlovid & Rebound now?  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200054572 same drug/different patient;
Left arm appeared red with increasing swelling, largest noted about 12 cm.  Left upper extremity was hot, painful. Joint swelling developed in left shoulder and left elbow. Rash appears under eyes and both cheeks. Arm still remains red.
I began having seizures 2 weeks after my 1st shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Feb2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SEIZURE (medically significant) with onset 2021, outcome "unknown", described as "I began having seizures 2 weeks after my 1st shot".  Clinical information: Patient reported thank You (sarcasm intended) for ruining patient's life forever. After receiving 1 Covid shot in Feb2021 Patient began having seizures 2 weeks after 1st shot. Patient never had a seizure before in life nor anyone in patient's family! Patient know the company don't care, but patient do because patient's life will never be the same and had not been the same since 14Mar2021 Patient will never receive any compensation for the damage caused as well as others. Thanks for the he will you have put through.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Developed full body itch  covering face, neck, torso, limbs, feet which has persited for two days so far
Extremely greater arthritis pain in hands and arms weakness i legs and back light headed, dizzy Slight shortness of breath
vaccine clinic. Parent rescheduled appointment morning of clinic, administration and clinic staff did not receive updated information. Pt was called down to clinic and vaccinated based on printed  roster.
This spontaneous report was received from an unspecified reporter via Pfizer refers to a 15 year old patient. The patient was immunodeficient. The patient's medical history, concomitant medications were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (dose, dose number, frequency, lot #, expiry date, route and site of administration were not reported) for prophylaxis. Other suspect therapy which was given on the same time included PREVNAR 13 (dose, dose number, frequency, lot #, expiry date, route and site of administration were not reported) for prophylaxis (inappropriate schedule of drug administration). On an unknown date, the patient experienced thrombocytopenia and increased antibody titer (antibody test positive). Outcome of thrombocytopenia and antibody test positive was unknown. The reporter's causality assessment between the event and the suspect therapy was not reported. The patient was claiming for reimbursement from insurance company. Upon internal review, the event of thrombocytopenia was determined to be medically significant.
Patient was given the wrong dose of vaccine. Patient received 0.5mL when should have received 0.25. No adverse event noted.
Area of cellulitis x 2 cm around area of Varivax shot site: redness and warmth present x 4 days.
Patient noticed raised, red, swollen, bruised area on right arm (injection site) on 7/7/12 evening; she stated that area was itchy & painful & had a headache. She informed me on 7/8 & I recommended cold compress to injection site, TYLENOL and/or BENADRYL, and to contact Dr.; I contacted MD on 7/8 & she noted that there's nothing she would do differently.
SM developed redness, swelling, pain in triceps where he received his anthrax vaccine.
3 x 3 inch circular, raised rash; 3 x 3 inch circular, raised, red rash; 3 x 3 inch circular, raised, itchy rash; 3 x 3 inch circular, raised, hot rash; Headache after receiving first dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PAPULAR (3 x 3 inch circular, raised rash), RASH ERYTHEMATOUS (3 x 3 inch circular, raised, red rash), RASH PRURITIC (3 x 3 inch circular, raised, itchy rash), RASH (3 x 3 inch circular, raised, hot rash) and HEADACHE (Headache after receiving first dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013N20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension since 1985. Concomitant products included CARVEDILOL, ATORVASTATIN, LISINOPRIL, FAMOTIDINE and TAMSULOSIN for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced HEADACHE (Headache after receiving first dose). On 17-Mar-2021, the patient experienced RASH PAPULAR (3 x 3 inch circular, raised rash), RASH ERYTHEMATOUS (3 x 3 inch circular, raised, red rash), RASH PRURITIC (3 x 3 inch circular, raised, itchy rash) and RASH (3 x 3 inch circular, raised, hot rash). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Mar-2021, HEADACHE (Headache after receiving first dose) had resolved. On 26-Mar-2021, RASH PAPULAR (3 x 3 inch circular, raised rash), RASH ERYTHEMATOUS (3 x 3 inch circular, raised, red rash), RASH PRURITIC (3 x 3 inch circular, raised, itchy rash) and RASH (3 x 3 inch circular, raised, hot rash) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient visited doctor's office/urgent care visit due to the events Patient stated that the events were most likely caused by mRNA-1273. There were no other potential causes for the events. Patient had not experienced similar events in the past.   This case was linked to MOD-2021-064565 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow-up report included updates on patient demographics, race, concomitant medications, historical condition and outcome of events.
Shot given on Friday right deltoid became red on 07/28/2006 pm, increase swelling, redness over weekend.  Today presents in clinic with 2.5 by 3.5 area-complained of pain up to neck.  Patient has been taking hydroxyzine at home.  Symptoms decreased.
Death.  6/12/07 Received Autopsy Report which reveal COD as Undetermined.  Found unresponsive face down in bed between parents (anamnestic).  No anomalies, trauma, infectious agents or metabolic anomalies detected.  Toxicology revealed acetaminophen 6.5 mcg/mL; fluconazole + & caffeine. 6/25/07 Received vax record from pcp which confirms RO lot & dose # as reported.
10 minutes post vaccine developed unease, lip swelling, tongue tingling. Declined diphenhydramine and epinephrine since it was less severe than her previous reactions. Observed x 45 minutes. Symptoms resolved.
Pt recvd dose of Engerix B & p/each dose devel pain in lt shoulder muscle (deltoid) which radiates to the axilla; tx w/anti-inflammatory meds:ASA, Indocin & APAP;
Few minutes after giving the shot, patient returned in severe pain ,  starting from lower spine and going up to the heart.  Also had fast HR and high BP (EMS - 196/90).  Pt. sat down in chair , given cold water , while called 911 for check-up.  EMS recommended she see cardiologist , offered to drive her , but pt refused & went home.
Patient called on 1/17/20 after receiving a shingles and flu shot on 1/14/20 and said she has nausea and vomiting and fever/chills. She said she contacted her physician for medication for nausea and vomiting and he will call something in for her, but until then she is going to the doctor to be tested for the flu. She said she is starting to feel better and will continue to monitor.
Patient received 0.5ml of Covid Vaccine instead of the recommended 0.25ml for their age.
Heart palpitations started November 10, went to doctor and received cardiology referral November 22.
had her 1st dose of the vaccine last March 2, 2021 and tested positive for Covid after the 1st dose; had her 1st dose of the vaccine last March 2, 2021 and tested positive for Covid after the 1st dose; This is a spontaneous report received from a contactable consumer via Pfizer sponsored program for a herself. A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch number: Unknown, Expiration date: Unknown) via an unspecified route of administration on 02Mar2021 at SINGLE DOSE for COVID-19 Immunization. The patient's medical history and concomitant medications were not reported. The patient stated had her 1st dose of the vaccine last 02Mar2021 and tested positive for Covid after the 1st dose. It would be her last day of quarantine and she was scheduled to take the 2nd dose on 17Mar2021. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Headache and achy feeling that night.  Next day headache progressively got worse, queasy went to full nausea, trouble eating anything because of the nausea, aches in every joint, temperature reached 100.2 before going to bed (I almost never hit 97.2), chills.   Thursday, still have milder headache, still achy all over, arms just feel heavy, temp still at 98.9.   Friday, still have headache and loss of appetite, but much better
On 01/28/2002 reported to clinic sore, painful between shoulder and elbow area when used. No redness, no edema, no temperature. On 02/06/2002 continued to report achiness in upper arm.
Patient is a 42-year-old male who was diagnosed with asthma in 1984. He stated that he had good control of his asthma with Theodur, Singulair, and Maxair. He was able to perform his duties as postman walking 6 hrs a day and run 2 miles in 15 min without difficulty or use of inhaler. He reported normal pulmonary function tests in early June and no cough.   Patient received his first anthrax (AVA) on 27 Jun 04. Other than some slight soreness in his arm he reported no problems.   He received AVA #2 on 11 Jul 04. Initially he felt fine then 3-4 days later he developed a runny nose, shortness of breath, wheezing, cough, and slight sputum production. He thought that he was getting a cold, but symptoms progressed. He stated he was able to run on 22 Jul but required his inhaler to do so. He reports that since that time he is requiring the use of his inhaler 3-4 times daily.   Upon return home on 24 Jul 04 he sought medical attention and was told that the ragweed triggered his asthma. He was placed on Claritin, no steroids, and was using his Maxair every 4 hours. He did not notice any improvement and was no longer able to run. He stated that his repeat pulmonary function test in Sep was abnormal. He also stated he was waking up at night with coughing, but since a recent medication change that it has improved.   Patient reports that he has several allergies including cat dander. Since his return he has been around his daughter's cat. He reports that during prior exposure to ragweed he would have nasal congestion but nothing like this. This time he also has the sensation that his ears are blocked.
no adverse effect; 34 year old patient was administered one dose of PROQUAD; This spontaneous report was received from a nurse via field representative refers to a 34 year old patient of unknown gender. The patient's medical history, concurrent conditions, historical drugs, drug reactions/ allergies and concomitant medications were not reported. On 21-OCT-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) lot # S003178 and expiration date 30-JUL-2020, (strength, dose, frequency and route not reported) for prophylaxis. The patient's age at vaccination was 34 years (product administered to patient of inappropriate age). No adverse effects reported. No product quality complaint (PQC) was present.
grand mal sz according to RN @ MD office w/a duration of 30-45 secs;
Information has been received concerning a pt who was vaccinated with one dose of varicella vaccine. In June 2000 the pt developed chicken pox. the pt sought unspecified medical attention.
Pt. c/o chest pain. Vitals 132/80, RR 17, spO2 97%, HR 92. Patient examined, felt a lot better. Will follow up with primary care doctor.
pt received rsv vaccine on 10/05/23 at 10 am next day she had bodyache and low grade fever.. on 10/07/23 upon waking up she saw the bad rash over her shoulder and neck which the next day the rash progressed to other site..... for the next 2 days rash was very itching and worsend. on 10/11/23 the rash was gone and disappeared
pt recv vax 6NOV97 & 1hr p/vax pt exp one red bump approx 1.4 inches from the inj site, in armpit;
Left breast phlebitis began 17 days after vaccination, reaching worst symptoms 25 days after vaccination (3/8/2021) with pain, linear redness tracking along surface veins and (sub)cutaneous linear retractions extending from left axilla, across lateral breast quadrants, to lower left ribcage at mid-clavicular line.  Still present though gradually improving each day as of  4/2/2021.  Visited Dr. on 3/19/21 and she confirmed findings without obvious adenopathy or mass. She ordered diagnostic mammogram and ultrasound left breast which were done and found normal on 4/2/2021.
Stomach sensitivity, went in for endoscopy 8/25 found that I have Gastritis, Duodenitis, and Esophagitis. Unclear if the Plavix/baby asprin combo made my for more stomach acid, but found stomach pain more severe after each vaccine. I've had original 2, plus 2 boosters.
Patient took 2nd covid shot thursday running fever and has a headache; Patient took 2nd covid shot thursday running fever and has a headache; This is a spontaneous report from a contactable pharmacist. This pharmacist reported for a patient that: A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot Number unknown, expiration date unknown), via an unspecified route of administration on an unspecified date as dose 2, single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of Covid Shot on an unspecified date, as single dose for COVID-19 immunization. The pharmacist reported that the patient took 2nd COVID shot and on an unspecified date (on Thursday) running fever and has a headache, so MD advised to hold off on shot until fever goes down. Potentially next day. Pharmacist advised that they have not heard of any known DDI'S or adverse events associated with Dupixent and COVID vaccines. No additional information was provided and stated that If require additional information, please contact the reporter directly. The outcome of the events was unknown.  Follow-up attempts are needed; Information about lot/batch number has been requested.
No adverse effect; patients who received improperly stored GARDASIL 9 since 8/13/2019; This spontaneous report as received from a phlebotomist refers to a 13-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions and allergies was provided.  On an unknown date in 2019 (reported as since 13-AUG-2019), the patient was vaccinated with incorrect stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, lot # 1602281, expiration date 21-JUL-2021 (dose and route of administration were not reported) for prophylaxis. The temperature excursion occurred on 13-AUG-2019. The vaccine was stored in temperature 30.60 degrees Fahrenheit for 41 minutes and in temperature 56.80 degrees Fahrenheit for 4 hours 30 minutes. There was no previous temperature excursion. The digital data logger was involved. No adverse effects were reported.; Sender's Comments:  US-009507513-1909USA004622:
Pt woke up on 20MAR92 c/o stomach cramping & backache; mom took to ER immed; unsteady gait by time in ER; x-rays & blood drawn-neg results; neurologist say acute disturbance of gait; pt admitted; MRI done w/results essentially neg;
This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received both doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number and expiration date was not reported), via an unspecified route of administration on and unspecified dates in Dec2020 and Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 13Mar2021, the patient tested positive for the virus. Fortunately, the patient had a mild case. The seriousness of the event was considered as medically significant. Outcome of the events was unknown. Information on the lot/batch number has been requested.
Vaccine 3/22/21 - *swelling of lips 3/23/21 and took antihistamine and advil; 3/24/21 swelling increasing and began prednisone 20mg; 3/25/21 swelling decreasing but not completely yet  *Juvederm volbella injected in to lips in November, 2020
Patient's entire arm swelled from shoulder to elbow. Arm was warm to touch. No pain. Mom describes as puffy. Injection site hard. No fever. Urgent Care prescribed antibiotics x 3 days.
27FEB95 rash over trunk & arms-red & raised some fine & others wheels; t99.1; referred to pvt MD for f/u; tx prescribed: Hydroxycine q 12hrs;
Sore arm, uncontrollable shaking for hours, high temps (highest was 104.6, currently 102.3), severe headache, fatigue, aches in all joints.
Pt. c/o fever of 102.5, left arm red, swollen and warm.